Buddy Pouw

709 total citations
16 papers, 591 citations indexed

About

Buddy Pouw is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Buddy Pouw has authored 16 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 6 papers in Organic Chemistry. Recurrent topics in Buddy Pouw's work include Pharmacological Receptor Mechanisms and Effects (12 papers), Receptor Mechanisms and Signaling (8 papers) and Neuropeptides and Animal Physiology (4 papers). Buddy Pouw is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (12 papers), Receptor Mechanisms and Signaling (8 papers) and Neuropeptides and Animal Physiology (4 papers). Buddy Pouw collaborates with scholars based in United States. Buddy Pouw's co-authors include Rae R. Matsumoto, Wayne D. Bowen, Yun Liu, Ying Zhang, Brian R. de Costa, May Nour, Andrew Coop, Jeffrey M. Miller, Amy Hauck Newman and Stephen M. Husbands and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Pharmacology and Neuropharmacology.

In The Last Decade

Buddy Pouw

16 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Buddy Pouw United States 12 501 352 64 46 41 16 591
Nidhi Kaushal United States 14 390 0.8× 216 0.6× 47 0.7× 72 1.6× 76 1.9× 19 501
K. Becketts United States 10 199 0.4× 265 0.8× 54 0.8× 29 0.6× 23 0.6× 12 351
Sichen Chang United States 13 341 0.7× 287 0.8× 97 1.5× 38 0.8× 29 0.7× 34 463
Justin R. Nickell United States 12 230 0.5× 272 0.8× 83 1.3× 46 1.0× 13 0.3× 26 443
Dana E. Rodriguez United States 6 249 0.5× 379 1.1× 18 0.3× 85 1.8× 46 1.1× 7 445
Audrey A. Reid United States 10 348 0.7× 368 1.0× 52 0.8× 28 0.6× 9 0.2× 14 478
F. Ivy Carroll United States 8 217 0.4× 272 0.8× 69 1.1× 30 0.7× 6 0.1× 9 406
Sarah C. Hobbs United States 11 332 0.7× 249 0.7× 284 4.4× 39 0.8× 20 0.5× 13 600
Vladimir P. Grinevich United States 13 336 0.7× 168 0.5× 97 1.5× 68 1.5× 14 0.3× 24 450
Cheryse A. Furman United States 9 323 0.6× 376 1.1× 17 0.3× 24 0.5× 11 0.3× 9 492

Countries citing papers authored by Buddy Pouw

Since Specialization
Citations

This map shows the geographic impact of Buddy Pouw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Buddy Pouw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Buddy Pouw more than expected).

Fields of papers citing papers by Buddy Pouw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Buddy Pouw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Buddy Pouw. The network helps show where Buddy Pouw may publish in the future.

Co-authorship network of co-authors of Buddy Pouw

This figure shows the co-authorship network connecting the top 25 collaborators of Buddy Pouw. A scholar is included among the top collaborators of Buddy Pouw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Buddy Pouw. Buddy Pouw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pouw, Buddy, et al.. (2013). Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands. Bioorganic & Medicinal Chemistry Letters. 23(24). 6920–6922. 3 indexed citations
2.
Yang, Xiaowen, et al.. (2008). Trifluoromethoxyl Substituted Phenylethylene Diamines as High Affinity σ Receptor Ligands with Potent Anti-Cocaine Actions. Journal of Medicinal Chemistry. 51(11). 3322–3325. 3 indexed citations
3.
Matsumoto, Rae R., et al.. (2006). Effects of UMB24 and (±)-SM 21, putative σ2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice. Pharmacology Biochemistry and Behavior. 86(1). 86–91. 34 indexed citations
4.
Liu, Yun, et al.. (2005). Involvement of sigma (σ) receptors in the acute actions of methamphetamine: Receptor binding and behavioral studies. Neuropharmacology. 49(5). 638–645. 125 indexed citations
5.
Matsumoto, Rae R., et al.. (2004). Novel analogs of the σ receptor ligand BD1008 attenuate cocaine-induced toxicity in mice. European Journal of Pharmacology. 492(1). 21–26. 29 indexed citations
6.
Matsumoto, Rae R., et al.. (2004). Structure–activity comparison of YZ-069, a novel σ ligand, and four analogs in receptor binding and behavioral studies. Pharmacology Biochemistry and Behavior. 77(4). 775–781. 16 indexed citations
7.
Matsumoto, Rae R., et al.. (2002). Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides. Neuropharmacology. 42(8). 1043–1055. 84 indexed citations
8.
Matsumoto, Rae R., et al.. (2001). Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting σ1 receptors produce anti-cocaine effects in mice. European Journal of Pharmacology. 419(2-3). 163–174. 63 indexed citations
9.
Matsumoto, Rae R., Buddy Pouw, Wayne D. Bowen, et al.. (2001). Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters. Neuropharmacology. 41(7). 878–886. 46 indexed citations
10.
Matsumoto, Rae R., et al.. (2001). N-alkyl substituted analogs of the σ receptor ligand BD1008 and traditional σ receptor ligands affect cocaine-induced convulsions and lethality in mice. European Journal of Pharmacology. 411(3). 261–273. 56 indexed citations
11.
12.
Matsumoto, Rae R. & Buddy Pouw. (2000). Correlation between neuroleptic binding to σ1 and σ2 receptors and acute dystonic reactions. European Journal of Pharmacology. 401(2). 155–160. 41 indexed citations
13.
Pouw, Buddy, et al.. (1999). Design and Synthesis of Isoxazole Containing Bioisosteres of Epibatidine as Potent Nicotinic Acetylcholine Receptor Agonists.. Chemical and Pharmaceutical Bulletin. 47(10). 1501–1505. 10 indexed citations
14.
Pouw, Buddy, May Nour, & Rae R. Matsumoto. (1999). Effects of AMPA/kainate glutamate receptor antagonists on cocaine-induced convulsions and lethality in mice. European Journal of Pharmacology. 386(2-3). 181–186. 11 indexed citations
15.
Singh, Satendra, et al.. (1998). 2β-Substituted Analogues of 4‘-Iodococaine:  Synthesis and Dopamine Transporter Binding Potencies. Journal of Medicinal Chemistry. 41(13). 2380–2389. 3 indexed citations
16.
Singh, Satendra, et al.. (1997). Synthesis and Ligand Binding Studies of 4‘-Iodobenzoyl Esters of Tropanes and Piperidines at the Dopamine Transporter. Journal of Medicinal Chemistry. 40(16). 2474–2481. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026